<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The results obtained in the treatment of 37 children with non Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> belonging to GICOP between january 1982 and december 1986 are analysed </plain></SENT>
<SENT sid="1" pm="."><plain>The therapy depend on the anatomopathology following the working formulation; LSALL2 protocol is used in lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, Burkitt-82 in undifferentiated Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and COMP in the remaining complete remission was archived in 94.6% </plain></SENT>
<SENT sid="2" pm="."><plain>Murphy's classification is used </plain></SENT>
<SENT sid="3" pm="."><plain>Disease free survival is 81% at 30 months </plain></SENT>
<SENT sid="4" pm="."><plain>The actuarial survival is 0.81 for LL and 0.84 for BK at 48 months </plain></SENT>
<SENT sid="5" pm="."><plain>The results obtained in the treatment of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with Burkitt-82 protocol and specially the absence of <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> infiltration are remarkable </plain></SENT>
</text></document>